The bill SB 276 in Louisiana classifies mifepristone and misoprostol as controlled substances, impacting abortion access and raising concerns among doctors and advocates.
Supporters argue the bill protects pregnant individuals, while opponents fear restricted access to essential drugs beyond abortion due to reclassification as controlled substances.
[
add
]
[
|
|
...
]